Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Urgent Updates | February 2, 2022

TREATMENT OF MULTIDRUG-RESISTANT GRAM-NEGATIVE BACILLI CLINICAL PRACTICE GUIDELINES (ESCMID, 2021)

Guidelines for the treatment of multidrug-resistant gram-negative bacilli were published in December 2021 by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) with the endorsement of the European Society of Intensive Care Medicine (ESICM).

For bloodstream infection (BSI) and severe infection due to 3GCephRE, a carbapenem (imipenem or meropenem) is recommended. For BSI without septic shock, ertapenem may be used instead. Stepdown targeted therapy is good clinical practice after carbapenems once patients are stabilized. Full Access: Medscape

TWO POWERFUL DRUGS NOW ADDING TO US OVERDOSE CRISIS

Emerging reports show that two “little-known” drugs are making lethal new contributions to America’s drug overdose crisis. Para-fluorofentanyl and metonitazene are being seen more often by medical examiners looking into overdose deaths. They often are taken with — or mixed with — illicit fentanyl, the drug mainly responsible for the more than 100,000 U.S. overdose deaths in the last year.
Full access: Medscape

THE SILENT EPIDEMIC: MENTAL HEALTH OF CLINICIANS

 In surveys among the general populace since the start of the pandemic, 40% of respondents reported struggling with mental health, and claims of burnout rose 52%. 

With the COVID-19 pandemic, vulnerability and wellness became much more difficult to achieve. Long hours and high demand created the perceived need for strength and infallibility among clinicians. Nearly every state in the union has a program dedicated to the wellness of health care professionals who struggle with mental health and substance use disorders (SUDs).
Full Access: Doximity

OMICRON SUBVARIANT 1.5 TIMES MORE CONTAGIOUS THAN OMICRON

The Omicron subvariant, known as BA.2, spreads about 1.5 times faster than the original Omicron strain. BA.2 is more contagious, but it doesn’t appear to increase hospitalizations or reduce how well the vaccine works. The Omicron subvariant has been detected in at least 29 states in the U.S. and 56 countries. The U.S. has detected 188 infections, with the worldwide total nearing 25,000.
Full Access: Medscape